Accumulates in tissues of essential fatty acid deficient animals. Is not converted to prostaglandins and LTB4 but is converted to cysteinyl leukotrienes. Immunomodulatory and anti-inflammatory effects.
Product Details
| Formula: | C20H34O2 |
| |
| MW: | 306.5 |
| |
| CAS: | 20590-32-3 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | Colorless oil. |
| |
| Solubility: | Soluble in ethanol, DMSO, acetone, ethyl acetate or hexane. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Store, as supplied, at -20°C for up to 1 year. Store solutions under an inert atmosphere at -20°C for up to 3 months. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Essential fatty acid deficiency: probing the role of arachidonate in biology: J.B. Lefkowith, et al.; Adv. Prostaglandin Thromboxane Leukot. Res.
20, 224 (1990),
Abstract;
Essential fatty acid depletion of renal allografts and prevention of rejection: G. F. Schreiner, et al.; Science
240, 1032 (1988),
Abstract;
Essential fatty acid deficiency: a new look at an old problem: J.B. Lefkowith, et al.; Prostaglandins Leukot. Med.
23, 123 (1986),
Abstract;
